Regulate Anti Psychotic Drugs Now, UK

Help the Aged have backed an MPs bid to regulate the prescription of anti-psychotic drugs for people with dementia in care homes.

Seeing Alzheimer's Amyloids

In an important step toward demystifying the role protein clumps play in the development of neurodegenerative disease, researchers have created a stunning three-dimensional picture of an Alzheimer's peptide aggregate using electron microscopy. The study, in this week's issue of the Proceedings of the National Academy of Sciences, reports that researchers from Brandeis University in Waltham, Mass.

End-Stage Dementia Patients Deserve The Same Access To Palliative Care As People With Cancer

There is an urgent need to improve end-of-life care for older people in the final stages of dementia, according to an international review published in the May issue of Journal of Clinical Nursing. "We must act now to stop people with dementia from suffering from protracted, potentially uncomfortable and undignified deaths" says Jan Draper, Professor of Nursing for The Open University, UK.

Alzheimer' S Society Comment On A Review Of Palliative Care Published In The May Issue Of Journal Of Clinical Nursing, UK

One in three people over 65 will die with dementia and too many of them are subjected to an undignified and unnecessarily painful death. This is often because staff lack the specialist training to provide good care at the end of someone's life. It is vital that all people, not just those with cancer, benefit from good palliative care. The number of people living with dementia in the UK is set to soar to more than a million in less than twenty years.

Historically A Disappointment, Neuroprotective Drug Strategies Pursuing New Targets And Mechanisms

In terms of the number of people affected, neurological diseases that contributed to decline in neuronal function are sometimes considered the newest healthcare epidemic. With the number of cases of neurodegenerative conditions expected to grow dramatically, driven by the aging population in developed countries, this therapeutic area represents one of the most compelling in both commercial and human terms.

Model Shows How Mutation Tips Biochemistry To Cause Alzheimer's

Your fate can be determined by tiny events. Imagine you live in the city and you walk everywhere to get exercise - you are healthy and not afraid of getting mugged. You almost never eat breakfast so you don't stop at the donut shop on the way to work, until one day the manager replaces the girl at the counter with her pretty red-haired younger sister. This seemingly unimportant change in your world is just enough to overcome your ability to resist high-fat temptation.

Anti-Inflammatories Should Not Be Used To Prevent Alzheimer's, Study

Results of a US study of elderly men and women with a family history of Alzheimer's suggest that the nonsteroidal anti-inflammatory drugs (NSAIDs) naproxen and celecoxib did not improve cognitive function and the investigators recommended against using them to prevent Alzheimer's.

Caregivers For Alzheimer's Patients Record Life Stories With Project StoryKeeper

Project StoryKeeper, a non-profit organization dedicated to preserving family heritage and announced that new findings by the Alzheimer's Association are increasing the need to document the life stories of patients. Caregivers of Alzheimer's patients can get access to Project StoryKeeper's interviewing technology by visiting http://www.storykeeper.org.

Weight Link To Dementia

"Obesity doubles the risk of Alzheimer's" is the headline in the Daily Express. It and other news sources report new research which found that people who are obese have an increased risk of all types of dementia. Being underweight "increased the risk of any kind of dementia by 36 per cent, while being obese increased it by 42 per cent. For Alzheimer's disease, being obese increased the risk by 80 per cent", the newspaper says.

Mechanism Uncovered Of Action Of Antibiotic Able To Reduce Neuronal Cell Death In Brain

Research Highlights: Mechanism of action of compound found to induce neurotransmitter activity in brain cells The findings may lead researchers to develop potential novel therapies to treat Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease,